Top compounds associated with response to CCDC94


Feature Type Standardized
Nominal ANOVA
mRNA canertinib CTRPv2 pan-cancer AAC -0.038 0.3
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC -0.036 0.3
mRNA masitinib GDSC1000 pan-cancer AAC -0.034 0.3
mRNA Zebularine CTRPv2 pan-cancer AAC -0.036 0.3
mRNA BRD-K01737880 CTRPv2 pan-cancer AAC 0.13 0.3
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.3
mRNA ciclosporin CTRPv2 pan-cancer AAC -0.038 0.3
mRNA CAL-101 CTRPv2 pan-cancer AAC -0.037 0.3
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.037 0.3
mRNA pitstop2 CTRPv2 pan-cancer AAC 0.046 0.3
Download CSV